Cargando…
RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency
BACKGROUND: Current antiretroviral therapy is effective in controlling HIV-1 infection. However, cessation of therapy is associated with rapid return of viremia from the viral reservoir. Eradicating the HIV-1 reservoir has proven difficult with the limited success of latency reactivation strategies...
Autores principales: | Méndez, Catalina, Ledger, Scott, Petoumenos, Kathy, Ahlenstiel, Chantelle, Kelleher, Anthony D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172763/ https://www.ncbi.nlm.nih.gov/pubmed/30286764 http://dx.doi.org/10.1186/s12977-018-0451-0 |
Ejemplares similares
-
Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection
por: Agbosu, Esinam E., et al.
Publicado: (2022) -
Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing
por: Ahlenstiel, Chantelle, et al.
Publicado: (2015) -
Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing
por: Suzuki, Kazuo, et al.
Publicado: (2013) -
Promoter Targeting RNAs: Unexpected Contributors to the Control of HIV-1 Transcription
por: Suzuki, Kazuo, et al.
Publicado: (2015) -
Controlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional Cure
por: Ahlenstiel, Chantelle L., et al.
Publicado: (2015)